nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—Myocardial ischaemia—Sorafenib—liver cancer	0.0401	0.0511	CcSEcCtD
Fenoldopam—Cardiac failure—Sorafenib—liver cancer	0.024	0.0305	CcSEcCtD
Fenoldopam—Lactic dehydrogenase activity increased—Epirubicin—liver cancer	0.0233	0.0297	CcSEcCtD
Fenoldopam—Lactic dehydrogenase activity increased—Doxorubicin—liver cancer	0.0215	0.0274	CcSEcCtD
Fenoldopam—Hypokalaemia—Sorafenib—liver cancer	0.0213	0.0271	CcSEcCtD
Fenoldopam—Blood lactate dehydrogenase increased—Epirubicin—liver cancer	0.0205	0.0261	CcSEcCtD
Fenoldopam—Transaminases increased—Epirubicin—liver cancer	0.0196	0.0249	CcSEcCtD
Fenoldopam—Blood lactate dehydrogenase increased—Doxorubicin—liver cancer	0.019	0.0242	CcSEcCtD
Fenoldopam—Transaminases increased—Doxorubicin—liver cancer	0.0181	0.0231	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Sorafenib—liver cancer	0.0178	0.0226	CcSEcCtD
Fenoldopam—Myocardial infarction—Sorafenib—liver cancer	0.0177	0.0225	CcSEcCtD
Fenoldopam—Haemoglobin—Sorafenib—liver cancer	0.0163	0.0207	CcSEcCtD
Fenoldopam—Haemorrhage—Sorafenib—liver cancer	0.0162	0.0206	CcSEcCtD
Fenoldopam—Flushing—Sorafenib—liver cancer	0.015	0.0191	CcSEcCtD
Fenoldopam—Muscle spasms—Sorafenib—liver cancer	0.0135	0.0173	CcSEcCtD
Fenoldopam—Oliguria—Epirubicin—liver cancer	0.0129	0.0165	CcSEcCtD
Fenoldopam—Creatinine increased—Epirubicin—liver cancer	0.0125	0.0159	CcSEcCtD
Fenoldopam—Oliguria—Doxorubicin—liver cancer	0.012	0.0152	CcSEcCtD
Fenoldopam—Injection site reaction—Epirubicin—liver cancer	0.0118	0.0151	CcSEcCtD
Fenoldopam—Creatinine increased—Doxorubicin—liver cancer	0.0116	0.0148	CcSEcCtD
Fenoldopam—Blood urea increased—Epirubicin—liver cancer	0.0112	0.0143	CcSEcCtD
Fenoldopam—Injection site reaction—Doxorubicin—liver cancer	0.011	0.014	CcSEcCtD
Fenoldopam—Blood urea increased—Doxorubicin—liver cancer	0.0104	0.0133	CcSEcCtD
Fenoldopam—Dyspnoea—Sorafenib—liver cancer	0.0103	0.0131	CcSEcCtD
Fenoldopam—Constipation—Sorafenib—liver cancer	0.00983	0.0125	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Sorafenib—liver cancer	0.0094	0.012	CcSEcCtD
Fenoldopam—Abdominal pain—Sorafenib—liver cancer	0.00909	0.0116	CcSEcCtD
Fenoldopam—Body temperature increased—Sorafenib—liver cancer	0.00909	0.0116	CcSEcCtD
Fenoldopam—Cardiac failure—Epirubicin—liver cancer	0.00886	0.0113	CcSEcCtD
Fenoldopam—Cardiac failure—Doxorubicin—liver cancer	0.0082	0.0104	CcSEcCtD
Fenoldopam—Blood creatinine increased—Epirubicin—liver cancer	0.0081	0.0103	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Epirubicin—liver cancer	0.0079	0.0101	CcSEcCtD
Fenoldopam—Hypokalaemia—Epirubicin—liver cancer	0.00787	0.01	CcSEcCtD
Fenoldopam—Diarrhoea—Sorafenib—liver cancer	0.00787	0.01	CcSEcCtD
Fenoldopam—Dizziness—Sorafenib—liver cancer	0.0076	0.00969	CcSEcCtD
Fenoldopam—Blood creatinine increased—Doxorubicin—liver cancer	0.00749	0.00955	CcSEcCtD
Fenoldopam—Vomiting—Sorafenib—liver cancer	0.00731	0.00932	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Doxorubicin—liver cancer	0.00731	0.00931	CcSEcCtD
Fenoldopam—Hypokalaemia—Doxorubicin—liver cancer	0.00728	0.00928	CcSEcCtD
Fenoldopam—Angina pectoris—Epirubicin—liver cancer	0.00728	0.00928	CcSEcCtD
Fenoldopam—Headache—Sorafenib—liver cancer	0.0072	0.00918	CcSEcCtD
Fenoldopam—Nausea—Sorafenib—liver cancer	0.00683	0.0087	CcSEcCtD
Fenoldopam—Angina pectoris—Doxorubicin—liver cancer	0.00673	0.00858	CcSEcCtD
Fenoldopam—Urinary tract infection—Epirubicin—liver cancer	0.00648	0.00825	CcSEcCtD
Fenoldopam—Sweating—Epirubicin—liver cancer	0.00639	0.00814	CcSEcCtD
Fenoldopam—Bradycardia—Epirubicin—liver cancer	0.00609	0.00776	CcSEcCtD
Fenoldopam—Haemoglobin—Epirubicin—liver cancer	0.00601	0.00766	CcSEcCtD
Fenoldopam—Urinary tract infection—Doxorubicin—liver cancer	0.00599	0.00764	CcSEcCtD
Fenoldopam—Haemorrhage—Epirubicin—liver cancer	0.00598	0.00762	CcSEcCtD
Fenoldopam—Sweating—Doxorubicin—liver cancer	0.00591	0.00753	CcSEcCtD
Fenoldopam—Bradycardia—Doxorubicin—liver cancer	0.00563	0.00718	CcSEcCtD
Fenoldopam—Haemoglobin—Doxorubicin—liver cancer	0.00556	0.00709	CcSEcCtD
Fenoldopam—Flushing—Epirubicin—liver cancer	0.00555	0.00707	CcSEcCtD
Fenoldopam—Haemorrhage—Doxorubicin—liver cancer	0.00553	0.00705	CcSEcCtD
Fenoldopam—Flushing—Doxorubicin—liver cancer	0.00514	0.00655	CcSEcCtD
Fenoldopam—Tension—Epirubicin—liver cancer	0.00511	0.00651	CcSEcCtD
Fenoldopam—Nervousness—Epirubicin—liver cancer	0.00506	0.00644	CcSEcCtD
Fenoldopam—Back pain—Epirubicin—liver cancer	0.00504	0.00642	CcSEcCtD
Fenoldopam—Muscle spasms—Epirubicin—liver cancer	0.00501	0.00638	CcSEcCtD
Fenoldopam—Tension—Doxorubicin—liver cancer	0.00473	0.00602	CcSEcCtD
Fenoldopam—Nervousness—Doxorubicin—liver cancer	0.00468	0.00596	CcSEcCtD
Fenoldopam—Back pain—Doxorubicin—liver cancer	0.00466	0.00594	CcSEcCtD
Fenoldopam—Muscle spasms—Doxorubicin—liver cancer	0.00463	0.0059	CcSEcCtD
Fenoldopam—Palpitations—Epirubicin—liver cancer	0.0046	0.00586	CcSEcCtD
Fenoldopam—Chest pain—Epirubicin—liver cancer	0.00443	0.00565	CcSEcCtD
Fenoldopam—Anxiety—Epirubicin—liver cancer	0.00442	0.00563	CcSEcCtD
Fenoldopam—Palpitations—Doxorubicin—liver cancer	0.00426	0.00543	CcSEcCtD
Fenoldopam—Tachycardia—Epirubicin—liver cancer	0.00415	0.00528	CcSEcCtD
Fenoldopam—Hyperhidrosis—Epirubicin—liver cancer	0.00411	0.00523	CcSEcCtD
Fenoldopam—Chest pain—Doxorubicin—liver cancer	0.0041	0.00523	CcSEcCtD
Fenoldopam—Anxiety—Doxorubicin—liver cancer	0.00409	0.00521	CcSEcCtD
Fenoldopam—Hypotension—Epirubicin—liver cancer	0.00397	0.00506	CcSEcCtD
Fenoldopam—Insomnia—Epirubicin—liver cancer	0.00384	0.0049	CcSEcCtD
Fenoldopam—Tachycardia—Doxorubicin—liver cancer	0.00384	0.00489	CcSEcCtD
Fenoldopam—Hyperhidrosis—Doxorubicin—liver cancer	0.0038	0.00484	CcSEcCtD
Fenoldopam—Dyspnoea—Epirubicin—liver cancer	0.00379	0.00483	CcSEcCtD
Fenoldopam—Hypotension—Doxorubicin—liver cancer	0.00367	0.00468	CcSEcCtD
Fenoldopam—Constipation—Epirubicin—liver cancer	0.00363	0.00463	CcSEcCtD
Fenoldopam—Insomnia—Doxorubicin—liver cancer	0.00356	0.00453	CcSEcCtD
Fenoldopam—Dyspnoea—Doxorubicin—liver cancer	0.00351	0.00447	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Epirubicin—liver cancer	0.00347	0.00443	CcSEcCtD
Fenoldopam—Constipation—Doxorubicin—liver cancer	0.00336	0.00428	CcSEcCtD
Fenoldopam—Abdominal pain—Epirubicin—liver cancer	0.00336	0.00428	CcSEcCtD
Fenoldopam—Body temperature increased—Epirubicin—liver cancer	0.00336	0.00428	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Doxorubicin—liver cancer	0.00321	0.0041	CcSEcCtD
Fenoldopam—Body temperature increased—Doxorubicin—liver cancer	0.00311	0.00396	CcSEcCtD
Fenoldopam—Abdominal pain—Doxorubicin—liver cancer	0.00311	0.00396	CcSEcCtD
Fenoldopam—Diarrhoea—Epirubicin—liver cancer	0.00291	0.0037	CcSEcCtD
Fenoldopam—Dizziness—Epirubicin—liver cancer	0.00281	0.00358	CcSEcCtD
Fenoldopam—Vomiting—Epirubicin—liver cancer	0.0027	0.00344	CcSEcCtD
Fenoldopam—Diarrhoea—Doxorubicin—liver cancer	0.00269	0.00343	CcSEcCtD
Fenoldopam—Headache—Epirubicin—liver cancer	0.00266	0.00339	CcSEcCtD
Fenoldopam—Dizziness—Doxorubicin—liver cancer	0.0026	0.00331	CcSEcCtD
Fenoldopam—Nausea—Epirubicin—liver cancer	0.00252	0.00322	CcSEcCtD
Fenoldopam—Vomiting—Doxorubicin—liver cancer	0.0025	0.00319	CcSEcCtD
Fenoldopam—Headache—Doxorubicin—liver cancer	0.00246	0.00314	CcSEcCtD
Fenoldopam—Nausea—Doxorubicin—liver cancer	0.00234	0.00298	CcSEcCtD
Fenoldopam—DRD1—Signaling by GPCR—HRAS—liver cancer	5.18e-05	0.000241	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CD—liver cancer	5.18e-05	0.000241	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MAPK14—liver cancer	5.16e-05	0.00024	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—APC—liver cancer	5.15e-05	0.000239	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CG—liver cancer	5.15e-05	0.000239	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—PIK3CA—liver cancer	5.13e-05	0.000238	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SERPINE1—liver cancer	5.12e-05	0.000238	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—HRAS—liver cancer	5.11e-05	0.000237	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CD—liver cancer	5.1e-05	0.000237	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CDKN1B—liver cancer	5.09e-05	0.000237	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—KRAS—liver cancer	5.07e-05	0.000236	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ESR1—liver cancer	5.06e-05	0.000235	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—PIK3CA—liver cancer	5.05e-05	0.000235	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SERPINE1—liver cancer	5.04e-05	0.000234	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—AKT1—liver cancer	5.04e-05	0.000234	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CD—liver cancer	5.03e-05	0.000234	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—BRAF—liver cancer	5.03e-05	0.000233	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CDKN1B—liver cancer	5.02e-05	0.000233	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—F2—liver cancer	5e-05	0.000232	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—KRAS—liver cancer	4.99e-05	0.000232	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CASP3—liver cancer	4.99e-05	0.000232	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—PIK3CA—liver cancer	4.99e-05	0.000232	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL2—liver cancer	4.98e-05	0.000231	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—PIK3CA—liver cancer	4.98e-05	0.000231	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—AKT1—liver cancer	4.97e-05	0.000231	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ALB—liver cancer	4.97e-05	0.000231	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—IL6—liver cancer	4.96e-05	0.00023	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—RAF1—liver cancer	4.95e-05	0.00023	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CASP3—liver cancer	4.92e-05	0.000229	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL2—liver cancer	4.92e-05	0.000228	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—IL6—liver cancer	4.89e-05	0.000227	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CCND1—liver cancer	4.86e-05	0.000226	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—JUN—liver cancer	4.85e-05	0.000225	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—BRAF—liver cancer	4.84e-05	0.000225	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MTOR—liver cancer	4.83e-05	0.000224	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PIK3CB—liver cancer	4.83e-05	0.000224	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TP53—liver cancer	4.82e-05	0.000224	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CTNNB1—liver cancer	4.81e-05	0.000223	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCND1—liver cancer	4.79e-05	0.000223	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CG—liver cancer	4.79e-05	0.000222	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APC—liver cancer	4.79e-05	0.000222	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—JUN—liver cancer	4.78e-05	0.000222	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CTNNB1—liver cancer	4.75e-05	0.00022	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MMP9—liver cancer	4.72e-05	0.000219	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CD—liver cancer	4.7e-05	0.000218	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CDKN1A—liver cancer	4.7e-05	0.000218	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—PIK3CA—liver cancer	4.66e-05	0.000216	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—PIK3CA—liver cancer	4.66e-05	0.000216	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MMP9—liver cancer	4.65e-05	0.000216	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SERPINE1—liver cancer	4.65e-05	0.000216	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CDKN1A—liver cancer	4.64e-05	0.000215	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—RAF1—liver cancer	4.62e-05	0.000215	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—HRAS—liver cancer	4.62e-05	0.000214	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—HRAS—liver cancer	4.61e-05	0.000214	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—KRAS—liver cancer	4.6e-05	0.000214	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MAPK8—liver cancer	4.59e-05	0.000213	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—PIK3CA—liver cancer	4.59e-05	0.000213	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—AKT1—liver cancer	4.57e-05	0.000212	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—RAF1—liver cancer	4.55e-05	0.000211	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CDKN1B—liver cancer	4.54e-05	0.000211	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CD—liver cancer	4.53e-05	0.00021	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MAPK8—liver cancer	4.53e-05	0.00021	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MTOR—liver cancer	4.52e-05	0.00021	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CB—liver cancer	4.52e-05	0.00021	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—AKT1—liver cancer	4.51e-05	0.00021	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—BRAF—liver cancer	4.5e-05	0.000209	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—AKT1—liver cancer	4.49e-05	0.000208	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—PIK3CA—liver cancer	4.49e-05	0.000208	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SERPINE1—liver cancer	4.48e-05	0.000208	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CASP3—liver cancer	4.45e-05	0.000206	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CB—liver cancer	4.44e-05	0.000206	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MTOR—liver cancer	4.44e-05	0.000206	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL2—liver cancer	4.44e-05	0.000206	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—KRAS—liver cancer	4.43e-05	0.000206	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—IL6—liver cancer	4.42e-05	0.000205	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IL6—liver cancer	4.41e-05	0.000205	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CB—liver cancer	4.39e-05	0.000204	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCND1—liver cancer	4.33e-05	0.000201	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—JUN—liver cancer	4.32e-05	0.000201	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—HRAS—liver cancer	4.31e-05	0.0002	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CTNNB1—liver cancer	4.29e-05	0.000199	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—HRAS—liver cancer	4.24e-05	0.000197	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CDKN1B—liver cancer	4.24e-05	0.000197	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—VEGFA—liver cancer	4.24e-05	0.000197	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—PIK3CA—liver cancer	4.23e-05	0.000196	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CD—liver cancer	4.21e-05	0.000195	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MMP9—liver cancer	4.2e-05	0.000195	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—RAF1—liver cancer	4.2e-05	0.000195	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—STAT3—liver cancer	4.19e-05	0.000195	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—AKT1—liver cancer	4.19e-05	0.000195	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CDKN1A—liver cancer	4.19e-05	0.000194	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—VEGFA—liver cancer	4.18e-05	0.000194	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CDKN1B—liver cancer	4.17e-05	0.000194	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—PIK3CA—liver cancer	4.17e-05	0.000194	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SERPINE1—liver cancer	4.16e-05	0.000193	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CASP3—liver cancer	4.15e-05	0.000193	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL2—liver cancer	4.15e-05	0.000193	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—STAT3—liver cancer	4.14e-05	0.000192	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—IL6—liver cancer	4.13e-05	0.000192	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—AKT1—liver cancer	4.13e-05	0.000192	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—KRAS—liver cancer	4.12e-05	0.000191	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MTOR—liver cancer	4.1e-05	0.00019	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CB—liver cancer	4.1e-05	0.00019	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CASP3—liver cancer	4.09e-05	0.00019	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MAPK8—liver cancer	4.09e-05	0.00019	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL2—liver cancer	4.08e-05	0.00019	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—AKT1—liver cancer	4.08e-05	0.000189	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—PIK3CA—liver cancer	4.07e-05	0.000189	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—AKT1—liver cancer	4.07e-05	0.000189	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—IL6—liver cancer	4.06e-05	0.000189	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—RAF1—liver cancer	4.04e-05	0.000188	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCND1—liver cancer	4.04e-05	0.000188	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—JUN—liver cancer	4.03e-05	0.000187	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CTNNB1—liver cancer	4e-05	0.000186	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCND1—liver cancer	3.98e-05	0.000185	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—JUN—liver cancer	3.97e-05	0.000184	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CB—liver cancer	3.95e-05	0.000183	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MTOR—liver cancer	3.95e-05	0.000183	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CTNNB1—liver cancer	3.94e-05	0.000183	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MMP9—liver cancer	3.92e-05	0.000182	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—HRAS—liver cancer	3.91e-05	0.000182	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CDKN1A—liver cancer	3.91e-05	0.000182	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MYC—liver cancer	3.9e-05	0.000181	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TGFB1—liver cancer	3.89e-05	0.000181	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MMP9—liver cancer	3.86e-05	0.000179	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CDKN1A—liver cancer	3.85e-05	0.000179	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CDKN1B—liver cancer	3.84e-05	0.000179	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MYC—liver cancer	3.84e-05	0.000179	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TGFB1—liver cancer	3.84e-05	0.000178	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MAPK8—liver cancer	3.82e-05	0.000177	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—AKT1—liver cancer	3.81e-05	0.000177	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—AKT1—liver cancer	3.8e-05	0.000177	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—PIK3CA—liver cancer	3.78e-05	0.000176	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—VEGFA—liver cancer	3.77e-05	0.000175	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—HRAS—liver cancer	3.77e-05	0.000175	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CASP3—liver cancer	3.77e-05	0.000175	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL2—liver cancer	3.76e-05	0.000175	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MAPK8—liver cancer	3.76e-05	0.000174	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—RAF1—liver cancer	3.76e-05	0.000174	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—AKT1—liver cancer	3.75e-05	0.000174	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—IL6—liver cancer	3.74e-05	0.000174	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—STAT3—liver cancer	3.74e-05	0.000173	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CDKN1B—liver cancer	3.7e-05	0.000172	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCND1—liver cancer	3.67e-05	0.00017	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MTOR—liver cancer	3.67e-05	0.00017	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CB—liver cancer	3.67e-05	0.00017	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—AKT1—liver cancer	3.66e-05	0.00017	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—JUN—liver cancer	3.66e-05	0.00017	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CTNNB1—liver cancer	3.63e-05	0.000169	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CASP3—liver cancer	3.63e-05	0.000169	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL2—liver cancer	3.63e-05	0.000168	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—IL6—liver cancer	3.61e-05	0.000168	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—KRAS—liver cancer	3.6e-05	0.000167	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MMP9—liver cancer	3.56e-05	0.000165	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—KRAS—liver cancer	3.55e-05	0.000165	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CDKN1A—liver cancer	3.55e-05	0.000165	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCND1—liver cancer	3.53e-05	0.000164	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—JUN—liver cancer	3.53e-05	0.000164	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—VEGFA—liver cancer	3.52e-05	0.000164	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—HRAS—liver cancer	3.5e-05	0.000163	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CTNNB1—liver cancer	3.5e-05	0.000163	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—STAT3—liver cancer	3.49e-05	0.000162	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MYC—liver cancer	3.47e-05	0.000161	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—VEGFA—liver cancer	3.47e-05	0.000161	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MAPK8—liver cancer	3.46e-05	0.000161	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TGFB1—liver cancer	3.46e-05	0.000161	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—AKT1—liver cancer	3.45e-05	0.00016	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CDKN1B—liver cancer	3.44e-05	0.00016	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—STAT3—liver cancer	3.43e-05	0.000159	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MMP9—liver cancer	3.43e-05	0.000159	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CDKN1A—liver cancer	3.42e-05	0.000159	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—AKT1—liver cancer	3.4e-05	0.000158	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CASP3—liver cancer	3.37e-05	0.000157	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL2—liver cancer	3.37e-05	0.000156	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—IL6—liver cancer	3.35e-05	0.000156	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MAPK8—liver cancer	3.34e-05	0.000155	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—AKT1—liver cancer	3.33e-05	0.000155	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PIK3CA—liver cancer	3.31e-05	0.000154	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PIK3CA—liver cancer	3.29e-05	0.000153	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCND1—liver cancer	3.28e-05	0.000152	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—JUN—liver cancer	3.28e-05	0.000152	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PIK3CA—liver cancer	3.26e-05	0.000152	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CTNNB1—liver cancer	3.25e-05	0.000151	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MYC—liver cancer	3.24e-05	0.000151	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TGFB1—liver cancer	3.23e-05	0.00015	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—KRAS—liver cancer	3.21e-05	0.000149	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TP53—liver cancer	3.2e-05	0.000149	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—VEGFA—liver cancer	3.2e-05	0.000149	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MYC—liver cancer	3.19e-05	0.000148	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MMP9—liver cancer	3.19e-05	0.000148	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TGFB1—liver cancer	3.18e-05	0.000148	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CDKN1A—liver cancer	3.18e-05	0.000148	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—STAT3—liver cancer	3.17e-05	0.000147	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TP53—liver cancer	3.16e-05	0.000147	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MAPK8—liver cancer	3.1e-05	0.000144	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—AKT1—liver cancer	3.09e-05	0.000144	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—VEGFA—liver cancer	3.08e-05	0.000143	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—HRAS—liver cancer	3.06e-05	0.000142	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—STAT3—liver cancer	3.05e-05	0.000142	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—HRAS—liver cancer	3.02e-05	0.00014	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—KRAS—liver cancer	3e-05	0.000139	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—KRAS—liver cancer	2.95e-05	0.000137	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PIK3CA—liver cancer	2.95e-05	0.000137	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MYC—liver cancer	2.94e-05	0.000137	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TGFB1—liver cancer	2.94e-05	0.000136	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL6—liver cancer	2.93e-05	0.000136	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL6—liver cancer	2.89e-05	0.000134	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—VEGFA—liver cancer	2.86e-05	0.000133	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TP53—liver cancer	2.85e-05	0.000132	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MYC—liver cancer	2.83e-05	0.000132	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—STAT3—liver cancer	2.83e-05	0.000132	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TGFB1—liver cancer	2.83e-05	0.000131	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CA—liver cancer	2.75e-05	0.000128	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—HRAS—liver cancer	2.73e-05	0.000127	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—KRAS—liver cancer	2.72e-05	0.000126	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CA—liver cancer	2.71e-05	0.000126	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AKT1—liver cancer	2.7e-05	0.000126	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—AKT1—liver cancer	2.69e-05	0.000125	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CA—liver cancer	2.67e-05	0.000124	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AKT1—liver cancer	2.67e-05	0.000124	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TP53—liver cancer	2.66e-05	0.000124	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MYC—liver cancer	2.63e-05	0.000122	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TGFB1—liver cancer	2.63e-05	0.000122	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TP53—liver cancer	2.62e-05	0.000122	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—KRAS—liver cancer	2.62e-05	0.000122	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL6—liver cancer	2.61e-05	0.000121	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HRAS—liver cancer	2.55e-05	0.000118	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HRAS—liver cancer	2.51e-05	0.000116	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CA—liver cancer	2.5e-05	0.000116	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL6—liver cancer	2.44e-05	0.000113	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—KRAS—liver cancer	2.43e-05	0.000113	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TP53—liver cancer	2.42e-05	0.000112	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AKT1—liver cancer	2.41e-05	0.000112	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CA—liver cancer	2.41e-05	0.000112	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL6—liver cancer	2.4e-05	0.000111	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TP53—liver cancer	2.33e-05	0.000108	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HRAS—liver cancer	2.31e-05	0.000107	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AKT1—liver cancer	2.25e-05	0.000104	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CA—liver cancer	2.24e-05	0.000104	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HRAS—liver cancer	2.23e-05	0.000103	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AKT1—liver cancer	2.21e-05	0.000103	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL6—liver cancer	2.21e-05	0.000103	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—AKT1—liver cancer	2.18e-05	0.000101	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TP53—liver cancer	2.16e-05	0.0001	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL6—liver cancer	2.13e-05	9.9e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HRAS—liver cancer	2.07e-05	9.61e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AKT1—liver cancer	2.04e-05	9.48e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL6—liver cancer	1.98e-05	9.19e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AKT1—liver cancer	1.97e-05	9.13e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AKT1—liver cancer	1.83e-05	8.48e-05	CbGpPWpGaD
